Skip to main content
CYCLOPHARM LIMITED logo

CYCLOPHARM LIMITED — Investor Relations & Filings

Ticker · CYC ISIN · AU000000CYC5 LEI · 9845008C9R4608FB7007 ASX Manufacturing
Open in API
Filings indexed 777 across all filing types
Latest filing 2008-10-15 Share Issue/Capital Cha…
Country AU Australia
Listing ASX CYC

About CYCLOPHARM LIMITED

https://www.cyclopharm.com.au

Cyclopharm Limited focuses on the development and commercialization of specialized medical imaging technologies. Its primary product, Technegas, is an ultra-fine dispersion of carbon nano-particles labeled with Technetium-99m, utilized for functional lung ventilation imaging. This technology is used to diagnose Pulmonary Embolism by providing high-resolution images via the inhalation of a radioactive aerosol. Technegas is generated on-site using proprietary equipment and is compatible with SPECT and SPECT/CT imaging. The system is engineered to provide diagnostic clarity even in patients with underlying airway diseases. Beyond its primary diagnostic use, the company investigates applications for its technology in managing chronic obstructive pulmonary disease (COPD), asthma, and lung cancer.

Recent filings

Filing Released Lang Actions
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the number of shares issued, issue price, purpose of the issue, dates related to allotment and quotation, underwriting fees, and other procedural details. It references ASX (Australian Securities Exchange) rules and includes a quotation agreement section. The content is focused on announcing and applying for quotation of additional securities rather than providing financial statements or management commentary. This matches the definition of a Share Issue/Capital Change filing, which covers announcements regarding new share issues or capital changes. The document is over 10,000 characters and contains substantive details about the share issuance, not just a brief announcement or a report publication notice.
2008-10-15 English
Change in substantial holding 3 pages ?Kb
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 notice under the Corporations Act 2001, titled 'Notice of change of interests of substantial holder'. It details changes in voting power and shareholdings of a substantial holder in Cyclopharm Limited, including dates and amounts of on-market purchases. This type of filing is a notification of changes in significant share ownership levels, which corresponds to a Major Shareholding Notification. The document is not a financial report, earnings release, or management report, but a regulatory disclosure about shareholding changes.
2008-09-25 English
Investor Presentation - Audio Broadcast 2 pages ?Kb
Investor Presentation Classification · 95% confidence The document is an announcement dated 24 September 2008 from Cyclopharm Limited to the Australian Securities Exchange. It provides information about an audio broadcast investor presentation titled "Company Overview and Update" by the Managing Director. The content includes background information about the company and its products but does not contain detailed financial statements or substantive financial data. The document length is 3160 characters, which is relatively short and consistent with an announcement rather than a full report. The presence of a link to listen to the audio broadcast further supports that this is an announcement of a presentation rather than the presentation itself or a detailed report. Therefore, the document fits best into the category of Investor Presentation (IP).
2008-09-23 English
Investor Presentation 41 pages ?Kb
Investor Presentation Classification · 95% confidence The document is titled 'INVESTOR PRESENTATION' and dated 17 September 2008. It contains detailed information about the company's business overview, management team, products, market footprint, and strategic outlook. The content is typical of a presentation prepared for investors to provide insights into the company's operations, financial update, and future prospects. There is no indication that this is a formal regulatory filing like an annual or quarterly report, audit report, or earnings release. The length of the document (15,000 characters) and the detailed nature of the content further support that this is a presentation rather than a brief announcement or certification. Therefore, the document best fits the category of an Investor Presentation (IP).
2008-09-16 English
Half Yearly Report and Accounts 28 pages ?Kb
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Cyclopharm Limited Appendix 4D - Half Year Report' and references the half year ended 30 June 2008. It contains detailed financial data including revenues, profit, net tangible assets, and a comprehensive operating review. It also includes financial statements such as consolidated income statement, balance sheet, cash flow statement, and notes to the financial statements. The document is 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of detailed financial data and analysis for a half-year period aligns with the definition of an Interim / Quarterly Report (IR). The document is not merely an announcement or a certification, but a substantive financial report for a period shorter than a full fiscal year. H1 2008
2008-08-21 English
Half Year Presentation 8 pages ?Kb
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Cyclopharm Limited Half Year Presentation August 2008' and contains detailed financial data including profit and loss, balance sheet, operating cash flow, and divisional reviews for the half year ended 30 June 2008. It includes substantive financial statements and analysis for a period shorter than a full fiscal year, which aligns with the definition of an Interim / Quarterly Report. The document is approximately 4709 characters, which is sufficient to contain actual financial data rather than just an announcement or summary. There is no indication that this is a full annual report or just a presentation or announcement. Therefore, the document fits best under the category of Interim / Quarterly Report (IR). H1 2008
2008-08-21 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.